SPC Logo

Cerezyme 200 U Powder for concentrate for solution for infusion

Last Updated on eMC 07-Oct-2014 View document  | Genzyme Therapeutics Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 07-Oct-2014 and displayed until Current

Reasons for adding or updating:

  • Change to other sources of information section

Updated on 31-Aug-2012 and displayed until 07-Oct-2014

Reasons for adding or updating:

  • Removal/change of distributor

Updated on 02-Jun-2011 and displayed until 31-Aug-2012

Reasons for adding or updating:

  • Change to Further Information section
  • Change to date of revision

Updated on 01-Nov-2010 and displayed until 02-Jun-2011

Reasons for adding or updating:

  • Change to Further Information section
  • Change to date of revision

Updated on 07-Sep-2010 and displayed until 01-Nov-2010

Reasons for adding or updating:

  • Change/addition of instructions for reconstitution and/ or administration
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to storage instructions

Updated on 03-Aug-2009 and displayed until 07-Sep-2010

Reasons for adding or updating:

  • Change to side-effects

Updated on 14-Jan-2009 and displayed until 03-Aug-2009

Reasons for adding or updating:

  • Change to date of revision
  • Change to information about pregnancy or lactation

Updated on 06-Jun-2008 and displayed until 14-Jan-2009

Reasons for adding or updating:

  • Transfer to upgraded management system

Updated on 26-Nov-2007 and displayed until 06-Jun-2008

Reasons for adding or updating:

  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
  • Change to side-effects
  • Change to dosage and administration
  • Change to storage instructions
  • Change to Further Information section

Updated on 25-Aug-2006 and displayed until 26-Nov-2007

Reasons for adding or updating:

  • New PIL for eMC ie a PIL for an existing product but one that is new to the eMC

Company contact details

Genzyme Therapeutics

Company image
Address

4620 Kingsgate, Cascade Way, Oxford Business Park South, Oxford, Oxfordshire, OX4 2SU

Fax

+44 (0)1865 774 172

Medical Information e-mail
Medical Information Fax

+44 (0)1865 774 172

Telephone

+44 (0)1865 405 200

Medical Information Direct Line

+44 (0)1865 405 283

Customer Care direct line

+44 (0)1865 405 200

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Active ingredients

imiglucerase

Legal categories

POM - Prescription Only Medicine

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Find out more here.